Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1964 1
1965 1
1967 1
1977 1
1978 1
1979 1
1984 1
1986 2
1987 1
1988 2
1989 1
1990 2
1991 2
1992 5
1993 6
1994 2
1995 1
1996 4
1997 4
1998 3
1999 9
2000 5
2001 3
2002 9
2003 5
2004 7
2005 7
2006 9
2007 10
2008 7
2009 17
2010 16
2011 14
2012 24
2013 34
2014 32
2015 28
2016 40
2017 32
2018 36
2019 34
2020 59
2021 33
Text availability
Article attribute
Article type
Publication date

Search Results

470 results
Results by year
Filters applied: . Clear all
Page 1
Innate Immunity.
Kaur BP, Secord E. Kaur BP, et al. Pediatr Clin North Am. 2019 Oct;66(5):905-911. doi: 10.1016/j.pcl.2019.06.011. Pediatr Clin North Am. 2019. PMID: 31466680 Review.
Chrononutrition in the management of diabetes.
Henry CJ, Kaur B, Quek RYC. Henry CJ, et al. Among authors: kaur b. Nutr Diabetes. 2020 Feb 19;10(1):6. doi: 10.1038/s41387-020-0109-6. Nutr Diabetes. 2020. PMID: 32075959 Free PMC article. Review.
White paper on microbial anti-cancer therapy and prevention.
Forbes NS, Coffin RS, Deng L, Evgin L, Fiering S, Giacalone M, Gravekamp C, Gulley JL, Gunn H, Hoffman RM, Kaur B, Liu K, Lyerly HK, Marciscano AE, Moradian E, Ruppel S, Saltzman DA, Tattersall PJ, Thorne S, Vile RG, Zhang HH, Zhou S, McFadden G. Forbes NS, et al. Among authors: kaur b. J Immunother Cancer. 2018 Aug 6;6(1):78. doi: 10.1186/s40425-018-0381-3. J Immunother Cancer. 2018. PMID: 30081947 Free PMC article. Review.
Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia.
Ghorani E, Kaur B, Fisher RA, Short D, Joneborg U, Carlson JW, Akarca A, Marafioti T, Quezada SA, Sarwar N, Seckl MJ. Ghorani E, et al. Among authors: kaur b. Lancet. 2017 Nov 25;390(10110):2343-2345. doi: 10.1016/S0140-6736(17)32894-5. Lancet. 2017. PMID: 29185430 Free article. No abstract available.
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.
Geng F, Cheng X, Wu X, Yoo JY, Cheng C, Guo JY, Mo X, Ru P, Hurwitz B, Kim SH, Otero J, Puduvalli V, Lefai E, Ma J, Nakano I, Horbinski C, Kaur B, Chakravarti A, Guo D. Geng F, et al. Among authors: kaur b. Clin Cancer Res. 2016 Nov 1;22(21):5337-5348. doi: 10.1158/1078-0432.CCR-15-2973. Epub 2016 Jun 8. Clin Cancer Res. 2016. PMID: 27281560 Free PMC article.
PRMT5 as a druggable target for glioblastoma therapy.
Banasavadi-Siddegowda YK, Welker AM, An M, Yang X, Zhou W, Shi G, Imitola J, Li C, Hsu S, Wang J, Phelps M, Zhang J, Beattie CE, Baiocchi R, Kaur B. Banasavadi-Siddegowda YK, et al. Among authors: kaur b. Neuro Oncol. 2018 May 18;20(6):753-763. doi: 10.1093/neuonc/nox206. Neuro Oncol. 2018. PMID: 29106602 Free PMC article.
470 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page